NB600-1206
antibody from Novus Biologicals
Targeting: TTN
CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB600-1206 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB600-1206, RRID:AB_10003288
- Product name
- Mouse Monoclonal Titin Antibody
- Antibody type
- Monoclonal
- Description
- Unpurified. The antibody localizes titin (connectin) in skeletal and heart muscle of a wide variety of species from cold-blooded vertebrates to human. The antibody does not cross-react with nebulin. Likewise, it does not react with smooth muscle, non-muscle tissues, or cultured cells.
- Reactivity
- Human, Mouse, Rat, Chicken/Avian
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Immunopathology in the brain of mice following vertical transmission of Coxsackievirus B4.
S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue.
siRNA-mediated inhibition of skNAC and Smyd1 expression disrupts myofibril organization: Immunofluorescence and electron microscopy study in C2C12 cells.
Jmii H, Halouani A, Abdeli M, Aouni M, Fisson S, Jaïdane H
Microbial pathogenesis 2020 Mar;140:103965
Microbial pathogenesis 2020 Mar;140:103965
S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue.
Braumann S, Thottakara T, Stücker S, Reischmann-Düsener S, Krämer E, Groß J, Hirt MN, Doroudgar S, Carrier L, Friedrich FW
Frontiers in physiology 2018;9:1292
Frontiers in physiology 2018;9:1292
siRNA-mediated inhibition of skNAC and Smyd1 expression disrupts myofibril organization: Immunofluorescence and electron microscopy study in C2C12 cells.
Berkholz J, Eberle R, Boller K, Munz B
Micron (Oxford, England : 1993) 2018 May;108:6-10
Micron (Oxford, England : 1993) 2018 May;108:6-10
No comments: Submit comment
No validations: Submit validation data